Product
Trumenba
Aliases
Trumenba Vaccine
3 clinical trials
4 indications
Indication
GonorrheaIndication
ChlamydiaIndication
Meningococcal VaccinesIndication
Meningococcal VaccineClinical trial
Effect of Trumenba on Gonococcal Infections in Adolescents and Young Adults in the United States: A Retrospective Cohort StudyStatus: Recruiting, Estimated PCD: 2024-03-31
Clinical trial
A PHASE 4, OPEN-LABEL, SINGLE-ARM TRIAL TO DESCRIBE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF TRUMENBA(REGISTERED) WHEN ADMINISTERED TO IMMUNOCOMPROMISED PARTICIPANTS ≥10 YEARS OF AGEStatus: Completed, Estimated PCD: 2023-09-06
Clinical trial
A PHASE 3, RANDOMIZED, ACTIVE-CONTROLLED, OBSERVER-BLINDED TRIAL TO ASSESS THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MenABCWY IN HEALTHY PARTICIPANTS ≥10 TO <26 YEARS OF AGEStatus: Completed, Estimated PCD: 2022-07-24